139 related articles for article (PubMed ID: 11166282)
1. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes.
Nir A; Zhang DF; Fixler R; Burnett JC; Eilam Y; Hasin Y
Eur J Pharmacol; 2001 Feb; 412(3):195-201. PubMed ID: 11166282
[TBL] [Abstract][Full Text] [Related]
2. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
[TBL] [Abstract][Full Text] [Related]
4. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of endothelin-1 on C-type natriuretic peptide actions in rat cardiomyocytes.
Fixler R; Hasin Y; Eilam Y; Zhang DF; Nir A
Eur J Pharmacol; 2001 Jul; 423(2-3):95-8. PubMed ID: 11448471
[TBL] [Abstract][Full Text] [Related]
6. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
7. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
8. Effects of C-type natriuretic peptide on rat cardiac contractility.
Brusq JM; Mayoux E; Guigui L; Kirilovsky J
Br J Pharmacol; 1999 Sep; 128(1):206-12. PubMed ID: 10498853
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling.
Lee SJ; Kim SZ; Cui X; Kim SH; Lee KS; Chung YJ; Cho KW
Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H208-21. PubMed ID: 10644601
[TBL] [Abstract][Full Text] [Related]
10. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
11. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
12. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
13. The opposing effects of endothelin-1 and C-type natriuretic peptide on apoptosis of neonatal rat cardiac myocytes.
Han B; Fixler R; Beeri R; Wang Y; Bachrach U; Hasin Y
Eur J Pharmacol; 2003 Aug; 474(1):15-20. PubMed ID: 12909191
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes.
Su J; Scholz PM; Weiss HR
Exp Biol Med (Maywood); 2005 Apr; 230(4):242-50. PubMed ID: 15792945
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways.
Tokudome T; Horio T; Soeki T; Mori K; Kishimoto I; Suga S; Yoshihara F; Kawano Y; Kohno M; Kangawa K
Endocrinology; 2004 May; 145(5):2131-40. PubMed ID: 14749356
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization.
Simon A; Harrington EO; Liu GX; Koren G; Choudhary G
Am J Physiol Lung Cell Mol Physiol; 2009 Feb; 296(2):L248-56. PubMed ID: 19036874
[TBL] [Abstract][Full Text] [Related]
17. Ammonia inhibits the C-type natriuretic peptide-dependent cyclic GMP synthesis and calcium accumulation in a rat brain endothelial cell line.
Konopacka A; Zielińska M; Albrecht J
Neurochem Int; 2008 May; 52(6):1160-6. PubMed ID: 18222015
[TBL] [Abstract][Full Text] [Related]
18. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
[TBL] [Abstract][Full Text] [Related]
19. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
[TBL] [Abstract][Full Text] [Related]
20. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
